Paraplegia following intrathecal chemotherapy.
D000293:Adolescent; D000438:Alcohols / Q000008:administration & dosage / Q000009:adverse effects*; D001344:Autopsy; D001593:Benzyl Compounds / Q000008:administration & dosage* / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D007938:Leukemia / Q000188:drug therapy; D004915:Leukemia, Erythroblastic, Acute / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D010226:Parabens / Q000008:administration & dosage / Q000009:adverse effects*; D010264:Paraplegia / Q000139:chemically induced*; D010592:Pharmaceutic Aids / Q000009:adverse effects; D013126:Spinal Nerve Roots / Q000187:drug effects; D013997:Time Factors
D000438:Alcohols; D001593:Benzyl Compounds; D010226:Parabens; D010592:Pharmaceutic Aids; D003561:Cytarabine; D008727:Methotrexate